Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,745Revenue (TTM) $M1,347Net Margin (%)6.2Altman Z-Score3.9
Enterprise Value $M8,543EPS (TTM) $0.4Operating Margin %8.0Piotroski F-Score--
P/E(ttm)94.5Beneish M-Score--Pre-tax Margin (%)4.8Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %2.9Quick Ratio2.3Cash flow > EarningsN
Price/Sales5.95-y EBITDA Growth Rate %1.9Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow30.8y-y EBITDA Growth Rate %-10.8ROA % (ttm)2.5Higher Current Ratio y-yN
Dividend Yield %--PEG50.7ROE % (ttm)4.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M228ROIC % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

QGEN is held by these investors:



QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

Quarterly/Annual Reports about QGEN:

    News about QGEN:

    Articles On GuruFocus.com
    French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test Jun 22 2017 
    QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval Jun 08 2017 
    QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platfor Jun 06 2017 
    QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immun Jun 03 2017 
    Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Jun 03 2017 
    QIAGEN Reports Results for First Quarter 2017 May 02 2017 
    QIAGEN Partners With Maccura to Localize and Commercialize GeneReader NGS System in China May 02 2017 
    New Research Suggests Potential for Additional Clinical Utility of QIAGEN's QuantiFERON-TB Gold Plus Apr 12 2017 
    QIAGEN Posts 2016 Annual Report on its Website Apr 06 2017 
    QIAGEN N.V. to Report First Quarter 2017 Results Apr 06 2017 

    More From Other Websites
    ETFs with exposure to QIAGEN NV : June 22, 2017 Jun 22 2017
    French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test Jun 22 2017
    QIAGEN NV :QGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Jun 16 2017
    QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval Jun 08 2017
    QIAGEN Strengthens Cancer Research Foothold on New License Jun 06 2017
    QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony... Jun 06 2017
    QIAGEN & Bristol-Myers Squibb Partner on Cancer Research Jun 05 2017
    Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression... Jun 03 2017
    QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for... Jun 03 2017
    3 Top Gene-Sequencing Stocks Poised for Solid Growth May 31 2017
    Edited Transcript of QGEN earnings conference call or presentation 3-May-17 1:00pm GMT May 11 2017
    Blog Coverage: INC Research Holdings Acquires Privately Held inVentiv Health May 11 2017
    Qiagen Banks on Molecular Diagnostic amid Currency Woes May 08 2017
    QIAGEN NV's Getting It Done May 04 2017
    QIAGEN (QGEN) Beats Q1 Earnings Estimates, Retains View May 03 2017
    Qiagen beats Street 1Q forecasts May 02 2017
    QIAGEN Reports Results for First Quarter 2017 May 02 2017
    QIAGEN Partners With Maccura to Localize and Commercialize GeneReader NGS System in China May 02 2017
    QIAGEN NV – Value Analysis (NASDAQ:QGEN) : April 26, 2017 Apr 26 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}